{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:37:04Z","timestamp":1792705024920,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejso.2025.110511","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:57:16Z","timestamp":1760655436000},"page":"110511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgery"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7934-6156","authenticated-orcid":false,"given":"Capucine","family":"Barjot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain-David","family":"Seban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Darrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Cabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Guillaume","family":"Feron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fourchotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Couturaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-4011","authenticated-orcid":false,"given":"Enora","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ejso.2025.110511_bib1","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2025.110511_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2326-6066.CIR-14-0133","article-title":"PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer","volume":"3","author":"Wimberly","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.ejso.2025.110511_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejso.2025.110511_bib4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of pembrolizumab with tumor response and survival among patients with advanced melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejso.2025.110511_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jtcvs.2021.02.099","article-title":"Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non\u2013small cell lung cancer","volume":"163","author":"Tong","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110511_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.athoracsur.2018.02.030","article-title":"Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors","volume":"106","author":"Bott","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejso.2025.110511_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1078196","article-title":"Safety and short-term outcomes of laparoscopic surgery for advanced gastric cancer after neoadjuvant immunotherapy: a retrospective cohort study","volume":"13","author":"Su","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2025.110511_bib8","article-title":"Perioperative outcomes of minimally invasive esophagectomy after neoadjuvant immunotherapy for patients with locally advanced esophageal squamous cell carcinoma","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110511_bib9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hed.26601","article-title":"Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer","volume":"43","author":"Mays","year":"2021","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ejso.2025.110511_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/646511","article-title":"Determinants of clean surgical wound infections for breast procedures at an oncology center","volume":"13","author":"Rotstein","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110511_bib11","first-page":"431","article-title":"Complications in breast surgery","volume":"87","author":"Vitug","year":"2007","journal-title":"Surg Clin"},{"issue":"3","key":"10.1016\/j.ejso.2025.110511_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.surg.2012.05.001","article-title":"Impact of neoadjuvant chemotherapy on wound complications after breast surgery","volume":"152","author":"Decker","year":"2012","journal-title":"Surgery"},{"issue":"13","key":"10.1016\/j.ejso.2025.110511_bib13","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/cncr.25872","article-title":"Impact of neoadjuvant chemotherapy on breast reconstruction","volume":"117","author":"Hu","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.110511_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00000658-199102000-00006","article-title":"Mastectomy following preoperative chemotherapy strict operative criteria control operative morbidity","volume":"213","author":"Broadwater","year":"1991","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110511_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejso.2021.09.007","article-title":"Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: a systematic review and meta-analysis","volume":"48","author":"Lorentzen","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110511_bib16","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0960-9776(23)00242-4","article-title":"P125 neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study","volume":"68","author":"K\u00fcmmel","year":"2023","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.ejso.2025.110511_bib17","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1245\/s10434-024-15359-w","article-title":"Impact of neoadjuvant chemoimmunotherapy on surgical outcomes and time to radiation in triple-negative breast cancer","volume":"31","author":"Myers","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110511_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12672-024-01349-7","article-title":"Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer","volume":"15","author":"Holt","year":"2024","journal-title":"Discov Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110511_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijsu.2014.01.012","article-title":"Standardization of morbidity assessment in breast cancer surgery using the clavien dindo classification","volume":"12","author":"Panhofer","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2025.110511_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1176609","article-title":"Impact of oncoplasty in increasing breast conservation rates post neo-adjuvant chemotherapy","volume":"13","author":"Koppiker","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110511_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/BCTT.S113742","article-title":"Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature","volume":"9","author":"Campbell","year":"2017","journal-title":"BCTT"},{"issue":"2","key":"10.1016\/j.ejso.2025.110511_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SAP.0b013e3182605598","article-title":"A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique","volume":"72","author":"Losken","year":"2014","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ejso.2025.110511_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijsu.2016.01.001","article-title":"Six-year follow-up of patients treated with oncoplastic reduction mammoplasty: a cohort study","volume":"26","author":"Kabir","year":"2016","journal-title":"Int J Surg"},{"issue":"10","key":"10.1016\/j.ejso.2025.110511_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ciresp.2019.07.003","article-title":"Reconstrucci\u00f3n inmediata mediante implante directo tras quimioterapia neoadyuvante. \u00bfEs una pr\u00e1ctica segura?","volume":"97","author":"Allu\u00e9 Caba\u00f1uz","year":"2019","journal-title":"Cirug\u00eda Espa\u00f1ola"},{"issue":"10","key":"10.1016\/j.ejso.2025.110511_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamasurg.2018.1687","article-title":"Comparison of 2-Year complication rates among common techniques for postmastectomy breast reconstruction","volume":"153","author":"Bennett","year":"2018","journal-title":"JAMA Surg"},{"issue":"10459","key":"10.1016\/j.ejso.2025.110511_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2025.110511_bib27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1245\/s10434-023-14541-w","article-title":"Axillary nodal metastases conversion and perioperative complications with neoadjuvant pembrolizumab therapy in triple-negative breast cancer","volume":"31","author":"Woodfin","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110511_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.amjsurg.2020.02.061","article-title":"Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates","volume":"219","author":"Sutton","year":"2020","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110511_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ejcts\/ezab007","article-title":"Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer","volume":"60","author":"Romero Rom\u00e1n","year":"2021","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"5","key":"10.1016\/j.ejso.2025.110511_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejso.2019.11.520","article-title":"Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: a systematic review and meta-analysis","volume":"46","author":"Machida","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"22","key":"10.1016\/j.ejso.2025.110511_bib31","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2025.110511_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:57:24Z","timestamp":1764028644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0748798325009394"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110511","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110511"}}